No abstract available
MeSH terms
-
Cost-Benefit Analysis
-
Diabetes Mellitus, Type 2 / diagnosis*
-
Diabetes Mellitus, Type 2 / economics
-
Diabetes Mellitus, Type 2 / prevention & control
-
Glucose Intolerance / diagnosis
-
Glucose Intolerance / epidemiology
-
Health Promotion
-
Humans
-
Mass Screening / economics*
-
Mass Screening / methods
-
Quality-Adjusted Life Years
-
United States / epidemiology